Barbara G. Utterback

2.3k total citations · 1 hit paper
21 papers, 1.5k citations indexed

About

Barbara G. Utterback is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Barbara G. Utterback has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Barbara G. Utterback's work include Sepsis Diagnosis and Treatment (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Chemical Synthesis and Analysis (3 papers). Barbara G. Utterback is often cited by papers focused on Sepsis Diagnosis and Treatment (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Chemical Synthesis and Analysis (3 papers). Barbara G. Utterback collaborates with scholars based in United States, France and Belgium. Barbara G. Utterback's co-authors include Pierre‐François Laterre, S. Betty Yan, Howard Levy, William L. Macias, Edward Abraham, Bruce R. Basson, Rolf Rossaint, D. Perrotin, Álvaro Réa-Neto and Rekha Garg and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Barbara G. Utterback

21 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

2005 567 citations Edward Abraham, Pierre‐François Laterre et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara G. Utterback United States	13	937	334	311	208	187	21	1.5k
David P. Sundin United States	15	931 1.0×	315 0.9×	290 0.9×	239 1.1×	216 1.2×	19	1.7k
F. Schindel Germany	10	717 0.8×	293 0.9×	379 1.2×	171 0.8×	141 0.8×	13	1.2k
Burkhard Vangerow United States	9	626 0.7×	263 0.8×	136 0.4×	246 1.2×	109 0.6×	14	1.1k
Argirios Ε. Tsantes Greece	24	472 0.5×	441 1.3×	454 1.5×	274 1.3×	285 1.5×	104	1.9k
Thomas Pernerstorfer Austria	23	411 0.4×	227 0.7×	395 1.3×	354 1.7×	395 2.1×	58	1.7k
Neil Boyce Australia	29	457 0.5×	216 0.6×	105 0.3×	430 2.1×	130 0.7×	81	2.3k
Taekyu Hwang United States	7	1.1k 1.1×	399 1.2×	56 0.2×	345 1.7×	139 0.7×	8	2.1k
Marcella C.A. Müller Netherlands	15	365 0.4×	400 1.2×	146 0.5×	220 1.1×	103 0.6×	59	1.8k
Yoke Lin Fung Australia	24	221 0.2×	419 1.3×	335 1.1×	242 1.2×	160 0.9×	89	2.1k
Peter Hellstern Germany	28	202 0.2×	451 1.4×	1.1k 3.6×	328 1.6×	500 2.7×	115	2.6k

Countries citing papers authored by Barbara G. Utterback

Since Specialization

Citations

This map shows the geographic impact of Barbara G. Utterback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara G. Utterback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara G. Utterback more than expected).

Fields of papers citing papers by Barbara G. Utterback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara G. Utterback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara G. Utterback. The network helps show where Barbara G. Utterback may publish in the future.

Co-authorship network of co-authors of Barbara G. Utterback

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara G. Utterback. A scholar is included among the top collaborators of Barbara G. Utterback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara G. Utterback. Barbara G. Utterback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hall, Jerry, Fujun Wang, Tina M. Oakes, et al.. (2010). Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials. Expert Opinion on Drug Safety. 9(4). 525–537. 20 indexed citations

Laterre, Pierre‐François, David R. Nelson, William L. Macias, et al.. (2007). International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety. Journal of Critical Care. 22(2). 142–152. 15 indexed citations

Goldstein, Brahm, Simon Nadel, Mark Peters, et al.. (2006). ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*. Pediatric Critical Care Medicine. 7(3). 200–211. 38 indexed citations

Abraham, Edward, Pierre‐François Laterre, Rekha Garg, et al.. (2005). Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death. New England Journal of Medicine. 353(13). 1332–1341. 567 indexed citations breakdown →

LaRosa, Steven P., Steven M. Opal, Barbara G. Utterback, et al.. (2005). Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei. International Journal of Infectious Diseases. 10(1). 25–31. 34 indexed citations

Kinasewitz, Gary T., S. Betty Yan, Bruce R. Basson, et al.. (2004). Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Critical Care. 8(2). 291 indexed citations

Dhainaut, Jean-François, Pierre-François Laterre, Steven P. LaRosa, et al.. (2003). The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*. Critical Care Medicine. 31(9). 2291–2301. 69 indexed citations

Dhainaut, Jean-François, Pierre‐François Laterre, Jonathan Janes, et al.. (2003). Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Medicine. 29(6). 894–903. 109 indexed citations

Mesters, Rolf M., Barbara G. Utterback, S. Betty Yan, et al.. (2000). Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Critical Care Medicine. 28(7). 2209–2216. 158 indexed citations

10.

Fisher, Matthew J., Bruce P. Gunn, Allen D. Kline, et al.. (1997). Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-Turn: Potent Antagonists of Platelet Glycoprotein IIb−IIIa. Journal of Medicinal Chemistry. 40(13). 2085–2101. 37 indexed citations

11.

Sall, Daniel J., Ann Arfsten, Jefferson R. McCowan, et al.. (1997). Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists. Journal of Medicinal Chemistry. 40(18). 2843–2857. 15 indexed citations

12.

Fisher, Matthew J., Bruce P. Gunn, Allen D. Kline, et al.. (1997). Dihydroisoquinolone RGD mimics. Exploration of the aspartate isostere. Bioorganic & Medicinal Chemistry Letters. 7(19). 2537–2542. 8 indexed citations

13.

Sall, Daniel J., Ann Arfsten, Jefferson R. McCowan, et al.. (1996). Platelet glycoprotein IIb–IIIa receptor (GPIIb–IIIa) antagonists derived from amidinoindoles. Bioorganic & Medicinal Chemistry Letters. 6(1). 81–86. 4 indexed citations

14.

Kramer, Ruth M., Edda F. Roberts, Paul A. Hyslop, et al.. (1995). Differential Activation of Cytosolic Phospholipase A2 (cPLA2) by Thrombin and Thrombin Receptor Agonist Peptide in Human Platelets. EVIDENCE FOR ACTIVATION OF cPLA2 INDEPENDENT OF THE MITOGEN-ACTIVATED PROTEIN KINASES ERK1/2. Journal of Biological Chemistry. 270(24). 14816–14823. 114 indexed citations

15.

Jakubowski, Joseph A., Barbara G. Utterback, Dale E. Mais, et al.. (1994). Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets. Prostaglandins. 47(3). 189–201. 5 indexed citations

16.

Takeuchi, Kumiko, et al.. (1994). Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition-I. Synthesis, structure-activity relationship, and evaluation of substituted (ω-phenyl-ω)-(3-pyridyl)alkenoic acids. Bioorganic & Medicinal Chemistry. 2(8). 743–755. 6 indexed citations

17.

Ladouceur, Gaétan, Dale E. Mais, Joseph A. Jakubowski, Barbara G. Utterback, & David W. Robertson. (1991). Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptors. Bioorganic & Medicinal Chemistry Letters. 1(3). 173–178. 3 indexed citations

18.

Bowling, Nancy, Virginia L. Wyss, Peter J. Gengo, et al.. (1990). Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion. European Journal of Pharmacology. 187(2). 155–164. 8 indexed citations

19.

Robertson, David W., Joseph H. Krushinski, Barbara G. Utterback, & Raymond F. Kauffman. (1989). Synthesis of a tritium-labeled indolidan analog and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites. Journal of Medicinal Chemistry. 32(7). 1476–1480. 15 indexed citations

20.

Wikel, James H., et al.. (1989). LY249933. Journal of Cardiovascular Pharmacology. 14(3). 483–491. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact